A study investigated the efficacy of MV-NIS for the treatment of ovarian cancer in athymic mice and showed that dual therapy with MV-CEA and MV-NIS has a better therapeutic effect compared to treatment with each virus alone [75]. The gene discussed is SLC5A5; the disease is ovarian carcinoma.